RaQualia Pharma Inc. vs Renascience Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Renascience Inc. is the larger company by market value: $163 M against $148 M for RaQualia Pharma Inc., 1.1 times as much (market caps of Mar 8, 2026). RaQualia Pharma Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet. Renascience Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Dec 2022: how each one's value moved, whatever its size.
Side by side
| Measure | RaQualia Pharma Inc. 4579.T | Renascience Inc. 4889.T |
|---|---|---|
| Profile | ||
| Country | 🇯🇵 Japan | 🇯🇵 Japan |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | — |
| Founded | — | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Mar 2026 | Market cap Mar 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, RaQualia Pharma Inc. or Renascience Inc.?
Renascience Inc. is the larger company by market value: $163 M against $148 M for RaQualia Pharma Inc., 1.1 times as much (market caps of Mar 8, 2026). RaQualia Pharma Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet. Renascience Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
More about RaQualia Pharma Inc.
More about Renascience Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.